Retatrutide is an investigational triple receptor agonist developed by Eli Lilly, targeting GLP-1, GIP, and glucagon receptors simultaneously
Other common side effects include: Abdominal distension Abdominal pain Diarrhea Fatigue Fecal incontinence Flatulence GERD Headache Severe diarrhea Upper respiratory tract infection Viral gastroenteritis Vomiting Precautions Linzess is contraindicated in people who are younger than six years of age
Originally developed to treat type 2 diabetes, semaglutide has since become one of the most effective medications for weight management
For maintenance purposes or use our whitening soap instead
Hyperkalemia is a concern with potassium-enriched salt substitutes for individuals with CKD [22,38]
Similar results showing the link between mitochondrial and synaptic dysfunctions affecting synaptic transmission in animal models with 22q11.2 microdeletion were also obtained by other researchers [360, 361]